Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact

Zeina A Kanafani1, John R Perfect

  • 1American University of Beirut Medical Center, Beirut, Lebanon. zk10@aub.edu.lb

Insights

Antifungal resistance in invasive fungal infections is a growing concern for immunocompromised patients. Understanding resistance mechanisms is key to improving treatment outcomes and patient survival.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections pose significant risks, especially for immunocompromised individuals.
  • Antifungal resistance is an increasing challenge, complicating treatment and affecting patient outcomes.
  • Current antifungal susceptibility testing has limitations in predicting clinical response.

Purpose of the Study:

  • To review the molecular mechanisms of antifungal resistance.
  • To discuss the clinical impact of antifungal resistance.
  • To highlight the importance of understanding clinical resistance in treatment failure.

Main Methods:

  • Literature review of molecular mechanisms of antifungal resistance.
  • Analysis of current guidelines for antifungal susceptibility testing.
  • Discussion of clinical resistance concepts.

Main Results:

  • Four primary mechanisms of azole resistance, involving altered gene expression, have been identified.
  • Mechanisms of resistance to polyenes and echinocandins require further investigation.
  • The correlation between in vitro antifungal susceptibility and clinical treatment response remains incomplete.

Conclusions:

  • A comprehensive understanding of both molecular and clinical resistance is crucial for managing invasive fungal infections.
  • Improved diagnostic and therapeutic strategies are needed to combat antifungal resistance.
  • Further research into resistance mechanisms is essential for developing effective treatments.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...